Study to collect samples for MIST analysis of Zibotentan and bioavailability of Zibotentan and Dapagliflozin in heatlhy participants
|Start Date:||July 2021|
|Primary Completion Date:
|Study Completion Date:
||Chronic Kidney Diseases|
For questions about your Trial Results Summary, please see Sponsor contact section within your Trial Results Summary.
Stay informed about new Trial Results Summaries with our email notification service
|United States of America, MD|| Brooklyn, MD, United States of America, 21225|